Tirzepatide

Product Specifications

Form: Lyophilized peptide powder

Strength: Add the product-specific strength

Peptide Length: 39 amino-acid residues

Peptide Classification: Synthetic acylated GIP and GLP-1 receptor-active research peptide

Modified Peptide Sequence: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(acylated)-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂

Structural Modifications: Aib substitutions at positions 2 and 13, a C20 fatty diacid side chain linked at Lys20 through a hydrophilic spacer, and C-terminal amidation

Molecular Formula: C225H348N48O68

Molecular Weight: Approximately 4813.5 g/mol

CAS Number: 2023788-19-2

Purity: ≥99%, where confirmed through batch-specific HPLC analysis

Appearance: White to off-white lyophilized powder

Intended Use: Laboratory research and analytical applications only

Research Applications

• Analytical characterization using HPLC, UPLC, and LC-MS workflows
• In vitro investigation of GIP and GLP-1 receptor-binding behavior
• Evaluation of receptor-associated intracellular signaling pathways
• Structure-activity analysis of modified incretin-related peptide sequences
• Investigation of lipid-linked peptide stability and protein-association properties
• Peptide identity, purity, molecular weight, and structural integrity assessment
• Comparative analysis of synthetic receptor-active peptides in non-clinical research models

Quality Documentation

A batch-specific Certificate of Analysis and applicable analytical documentation should be available for each lot. Peptide identity, modified sequence, purity, molecular weight, formulation details, and batch information should be verified against the records supplied with the individual product.

For Laboratory Research Use Only

This product is intended exclusively for controlled laboratory and in vitro research. Not for human or veterinary use. Not for diagnostic, therapeutic, clinical, cosmetic, or household applications.